Status:
TERMINATED
Surgical Management of Knee Septic Arthritis
Lead Sponsor:
Texas Tech University Health Sciences Center, El Paso
Conditions:
Septic Arthritis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Surgical excisional debridement is the mainstay of management in septic arthritis with necessary decompression, lavage, debridement, and partial synovectomy. However, there has been considerable debat...
Eligibility Criteria
Inclusion
- Adults (\>18 years old)
- Have a diagnosis of septic arthritis of the native knee (synovial WBC \>50k or acrystalline elevated synovial WBC \>25,000 with high clinical suspicion)
- Willingness to participate in the study
Exclusion
- Unwilling to participate in the study
- Acrystalline elevated synovial WBC \< 25,000
- Crystalline arthropathy with elevated synovial WBC but \< 50,000
- Have a history of a prior knee prosthesis (hemiarthroplasty, total knee arthroplasty)
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04786379
Start Date
April 1 2021
End Date
April 30 2022
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center of El Paso
El Paso, Texas, United States, 79905